Cargando…

New Perspectives on Criteria for the Determination of HCG Trigger Timing in GnRH Antagonist Cycles

The aim of this study was to investigate 2 quantification criteria to evaluate the developmental condition of follicles cohort and clarify their impacts upon the determining of human chorionic gonadotropin trigger timing and the reproductive outcome: the proportion of mature follicles in growing fol...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiaokun, Luo, Yingyi, Huang, Kejun, Li, Yubing, Xu, Yanwen, Zhou, Canquan, Mai, Qingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902421/
https://www.ncbi.nlm.nih.gov/pubmed/27196479
http://dx.doi.org/10.1097/MD.0000000000003691
_version_ 1782436988496904192
author Hu, Xiaokun
Luo, Yingyi
Huang, Kejun
Li, Yubing
Xu, Yanwen
Zhou, Canquan
Mai, Qingyun
author_facet Hu, Xiaokun
Luo, Yingyi
Huang, Kejun
Li, Yubing
Xu, Yanwen
Zhou, Canquan
Mai, Qingyun
author_sort Hu, Xiaokun
collection PubMed
description The aim of this study was to investigate 2 quantification criteria to evaluate the developmental condition of follicles cohort and clarify their impacts upon the determining of human chorionic gonadotropin trigger timing and the reproductive outcome: the proportion of mature follicles in growing follicles cohort on the day of human chorionic gonadotropin trigger and the peak estradiol level per oocyte on the day of human chorionic gonadotropin administration. Of the patients who underwent in vitro fertilization/ intracytoplasmic sperm injection-embryo transfer from 2011 to 2013, 492 controlled ovarian hyperstimulation cycles using gonadotropin-releasing hormone antagonists reaching the ovum pick-up and fresh embryo-transfer stage were included. Patients were divided into 3 groups according to their ≥17 mm/≥10 mm follicles ratio on the day of human chorionic gonadotropin administration (Low proportion: ≤30%, Middle proportion: 30%–60%, High proportion: ≥60%). Patients were divided into 5 groups according to their peak estradiol level/oocyte (Group A: <100 pg/mL per oocyte, Group B: 100–199 pg/mL per oocyte, Group C: 200–299 pg/mL per oocyte, Group D: 300–399 pg/mL per oocyte, Group E ≥400 pg/mL per oocyte) as well. Comparison among groups was made regarding ovarian stimulation characteristics, fertilization rate, good quality embryo rate, implantation, pregnancy, and live birth rates. On the basis of ≥17 mm/≥10 mm follicles ratio, the number of oocyte retrieved in low proportion group is more than other 2 groups. Implantation rate, clinical pregnancy, and live birth rate in high proportion group were 25.8%, 42.7%, and 31.1%, respectively, which is highest in 3 groups, and statistical significance existed between high and middle proportion groups. When the division is based on peak estradiol level/oocyte, the number of oocyte retrieved of ≥400 pg/mL per oocyte Group was significantly lowest compared with the other 4 groups. Matured ovum rate, fertilization rate, and good quality embryos rate exhibited an increasing trend as the peak estradiol level/oocyte increased. While pregnancy rate, implantation rate, and live birth rate were found to be lower whenever estradiol/oocyte ratio exceeded 400 pg/mL per oocyte or less than 100 pg/mL per oocyte, and there is statistical difference. Patients with the proportion of mature follicle reaching 60% on the day of human chorionic gonadotropin trigger and peak estradiol/oocyte level within 100∼399 pg/mL range can get a better pregnancy and implantation rate.
format Online
Article
Text
id pubmed-4902421
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49024212016-06-23 New Perspectives on Criteria for the Determination of HCG Trigger Timing in GnRH Antagonist Cycles Hu, Xiaokun Luo, Yingyi Huang, Kejun Li, Yubing Xu, Yanwen Zhou, Canquan Mai, Qingyun Medicine (Baltimore) 5600 The aim of this study was to investigate 2 quantification criteria to evaluate the developmental condition of follicles cohort and clarify their impacts upon the determining of human chorionic gonadotropin trigger timing and the reproductive outcome: the proportion of mature follicles in growing follicles cohort on the day of human chorionic gonadotropin trigger and the peak estradiol level per oocyte on the day of human chorionic gonadotropin administration. Of the patients who underwent in vitro fertilization/ intracytoplasmic sperm injection-embryo transfer from 2011 to 2013, 492 controlled ovarian hyperstimulation cycles using gonadotropin-releasing hormone antagonists reaching the ovum pick-up and fresh embryo-transfer stage were included. Patients were divided into 3 groups according to their ≥17 mm/≥10 mm follicles ratio on the day of human chorionic gonadotropin administration (Low proportion: ≤30%, Middle proportion: 30%–60%, High proportion: ≥60%). Patients were divided into 5 groups according to their peak estradiol level/oocyte (Group A: <100 pg/mL per oocyte, Group B: 100–199 pg/mL per oocyte, Group C: 200–299 pg/mL per oocyte, Group D: 300–399 pg/mL per oocyte, Group E ≥400 pg/mL per oocyte) as well. Comparison among groups was made regarding ovarian stimulation characteristics, fertilization rate, good quality embryo rate, implantation, pregnancy, and live birth rates. On the basis of ≥17 mm/≥10 mm follicles ratio, the number of oocyte retrieved in low proportion group is more than other 2 groups. Implantation rate, clinical pregnancy, and live birth rate in high proportion group were 25.8%, 42.7%, and 31.1%, respectively, which is highest in 3 groups, and statistical significance existed between high and middle proportion groups. When the division is based on peak estradiol level/oocyte, the number of oocyte retrieved of ≥400 pg/mL per oocyte Group was significantly lowest compared with the other 4 groups. Matured ovum rate, fertilization rate, and good quality embryos rate exhibited an increasing trend as the peak estradiol level/oocyte increased. While pregnancy rate, implantation rate, and live birth rate were found to be lower whenever estradiol/oocyte ratio exceeded 400 pg/mL per oocyte or less than 100 pg/mL per oocyte, and there is statistical difference. Patients with the proportion of mature follicle reaching 60% on the day of human chorionic gonadotropin trigger and peak estradiol/oocyte level within 100∼399 pg/mL range can get a better pregnancy and implantation rate. Wolters Kluwer Health 2016-05-20 /pmc/articles/PMC4902421/ /pubmed/27196479 http://dx.doi.org/10.1097/MD.0000000000003691 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5600
Hu, Xiaokun
Luo, Yingyi
Huang, Kejun
Li, Yubing
Xu, Yanwen
Zhou, Canquan
Mai, Qingyun
New Perspectives on Criteria for the Determination of HCG Trigger Timing in GnRH Antagonist Cycles
title New Perspectives on Criteria for the Determination of HCG Trigger Timing in GnRH Antagonist Cycles
title_full New Perspectives on Criteria for the Determination of HCG Trigger Timing in GnRH Antagonist Cycles
title_fullStr New Perspectives on Criteria for the Determination of HCG Trigger Timing in GnRH Antagonist Cycles
title_full_unstemmed New Perspectives on Criteria for the Determination of HCG Trigger Timing in GnRH Antagonist Cycles
title_short New Perspectives on Criteria for the Determination of HCG Trigger Timing in GnRH Antagonist Cycles
title_sort new perspectives on criteria for the determination of hcg trigger timing in gnrh antagonist cycles
topic 5600
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902421/
https://www.ncbi.nlm.nih.gov/pubmed/27196479
http://dx.doi.org/10.1097/MD.0000000000003691
work_keys_str_mv AT huxiaokun newperspectivesoncriteriaforthedeterminationofhcgtriggertimingingnrhantagonistcycles
AT luoyingyi newperspectivesoncriteriaforthedeterminationofhcgtriggertimingingnrhantagonistcycles
AT huangkejun newperspectivesoncriteriaforthedeterminationofhcgtriggertimingingnrhantagonistcycles
AT liyubing newperspectivesoncriteriaforthedeterminationofhcgtriggertimingingnrhantagonistcycles
AT xuyanwen newperspectivesoncriteriaforthedeterminationofhcgtriggertimingingnrhantagonistcycles
AT zhoucanquan newperspectivesoncriteriaforthedeterminationofhcgtriggertimingingnrhantagonistcycles
AT maiqingyun newperspectivesoncriteriaforthedeterminationofhcgtriggertimingingnrhantagonistcycles